Profile
Palle Christophersen is the founder of Cephagenix ApS, founded in 2020, and Saniona AB, founded in 2011, where the title held is Executive Vice President-Research.
The current job is Chief Scientific Officer at Saniona A. Former job includes Vice President & Director-Vitro Pharmacology at NTG Nordic Transport Group A from 1991 to 2012.
Education includes a doctorate from the University of Copenhagen.
Palle Christophersen active positions
| Companies | Position | Start |
|---|---|---|
| SANA AB | Founder | 01/01/2011 |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Chief Tech/Sci/R&D Officer | - |
Former positions of Palle Christophersen
| Companies | Position | End |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 01/01/2012 |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Founder | - |
Training of Palle Christophersen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
NTG Nordic Transport Group A/S
NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saniona AB
Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Cephagenix ApS
Cephagenix ApS BiotechnologyHealth Technology Engages in identifying and developing new, effective migraine therapies | Health Technology |
- Stock Market
- Insiders
- Palle Christophersen
















